261511-11-9

Basic information

• Product Name: (2S,3S,4S,5R,6S)-2-(methoxycarbonyl)-6-(4-methyl-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
• Synonyms: (2S,3S,4S,5R,6S)-2-(methoxycarbonyl)-6-(4-methyl-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
• CAS NO: 261511-11-9
• Molecular Weight: 469.402
• Mol File: 261511-11-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (2S,3S,4S,5R,6S)-2-(methoxycarbonyl)-6-(4-methyl-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,4S,5R,6S)-2-(methoxycarbonyl)-6-(4-methyl-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate(261511-11-9)
• EPA Substance Registry System: (2S,3S,4S,5R,6S)-2-(methoxycarbonyl)-6-(4-methyl-2-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate(261511-11-9)

Safety Data

• Hazardous Substances Data: 261511-11-9(Hazardous Substances Data)

Upstream product

• 119-33-5 4-methyl-2-nitrophenol 
• 7789-68-6 titanium(IV) bromide 
• 7355-18-2 (2S,3S,4S,5R,6S)-3,4,5,6-Tetraacetoxy-tetrahydro-pyran-2-carboxylic acid methyl ester 
• 21085-72-3 1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester 

Relevant articles and documents

GLUCURONIDE PRODRUGS OF TOFACITINIB

The invention relates to glucuronide prodrug compounds of the Janus kinase (JAK) inhibitor tofacitinib having formula (I): (Formula (I)) where A1 and R1 are as defined. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds to treat gastrointestinal inflammatory diseases; and processes and intermediates for preparing such compounds.

Proactive antitumor compounds

The present invention features proactive antitumor compounds of the following formula: wherein R1 is COOZ; Z being H, alkali metal, alkaline earth metal, an ammonium group which is optionally substituted with one or more alkyl groups, or a carboxyl protec